At present, the available evidence suggests that both GLP-1 agonist and SGLT2 inhibitors produce unfavourable outcomes, and should be avoided in pregnancy and during lactation
The human body needs a variety of vitamins and minerals to function properly
It's important to discuss your complete medical history with a health care provider before starting any new medication, including GLP-1 agonists
Whether you choose Noom Liraglutide or explore compounded GLP-1 options through PlexusDx, combining medication with behavioral change, baseline biomarker assessment, and ongoing provider oversight maximizes both safety and efficacy
It's no wonder that, since this new class of appetite-curbing GLP-1 medications, including Ozempic, Wegovy, and Zepbound, burst into public consciousness, nearly $1 billion of venture capital dollars have been injected into the growing sector of weight-loss companies, which is now awash with startups prescribing the drugs, according to PitchBook data from the last year and a half
Circulation 2024;150:1781-90.ArticlePubMed 120
